EBP50 exerts tumor suppressor activity by promoting cell apoptosis and retarding extracellular signal-regulated kinase activity
Abstract The expression of Ezrin-radixin-moesin-binding phosphoprotein-50 (EBP50) and the intragenic mutation of the ebp50 gene have been reported to correlate with human breast cancer development, but the exact impacts on breast cancer development and its molecular mechanism are not fully understood. In this study, we investigate the potential function of EBP50 through over-expression in the breast cancer cell line, MDA-MB-231, which has low EBP50 protein expression levels. The effects of EBP50 over-expression on cellular proliferation, anchorage-independent growth and apoptosis were examined. In addition, the activity of extracellular signal-regulated kinase (ERK) was also determined. Our results show that a decrease of cellular proliferation and attenuation of colony-forming ability were evident in MDA-MB-231 cells stably transfected with an EBP50 expressing plasmid (EBP-231) when compared with control cells. There was also a statistically significant increase in spontaneous apoptosis in EBP-231 cells accompanied by an attenuation in ERK activity. Altogether, our results suggest that restoring EBP50 expression could suppress breast cancer cell proliferation by promoting cell apoptosis and inhibiting ERK activity, and that EBP50 may be a target for development of diagnostics and therapeutics in breast cancer..
| Medienart: |
Artikel |
|---|
| Erscheinungsjahr: |
2009 |
|---|---|
| Erschienen: |
2009 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:38 |
|---|---|
| Enthalten in: |
Amino acids - 38(2009), 4 vom: 11. Dez., Seite 1261-1268 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Zheng, Jun-Fang [VerfasserIn] |
|---|
| Links: |
Volltext [lizenzpflichtig] |
|---|
| Themen: |
Anchorage-independent growth |
|---|
| Anmerkungen: |
© Springer-Verlag 2009 |
|---|
| doi: |
10.1007/s00726-009-0437-2 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
OLC2065587148 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | OLC2065587148 | ||
| 003 | DE-627 | ||
| 005 | 20230508130748.0 | ||
| 007 | tu | ||
| 008 | 200820s2009 xx ||||| 00| ||eng c | ||
| 024 | 7 | |a 10.1007/s00726-009-0437-2 |2 doi | |
| 035 | |a (DE-627)OLC2065587148 | ||
| 035 | |a (DE-He213)s00726-009-0437-2-p | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 082 | 0 | 4 | |a 570 |a 540 |q VZ |
| 084 | |a 12 |2 ssgn | ||
| 100 | 1 | |a Zheng, Jun-Fang |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a EBP50 exerts tumor suppressor activity by promoting cell apoptosis and retarding extracellular signal-regulated kinase activity |
| 264 | 1 | |c 2009 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
| 338 | |a Band |b nc |2 rdacarrier | ||
| 500 | |a © Springer-Verlag 2009 | ||
| 520 | |a Abstract The expression of Ezrin-radixin-moesin-binding phosphoprotein-50 (EBP50) and the intragenic mutation of the ebp50 gene have been reported to correlate with human breast cancer development, but the exact impacts on breast cancer development and its molecular mechanism are not fully understood. In this study, we investigate the potential function of EBP50 through over-expression in the breast cancer cell line, MDA-MB-231, which has low EBP50 protein expression levels. The effects of EBP50 over-expression on cellular proliferation, anchorage-independent growth and apoptosis were examined. In addition, the activity of extracellular signal-regulated kinase (ERK) was also determined. Our results show that a decrease of cellular proliferation and attenuation of colony-forming ability were evident in MDA-MB-231 cells stably transfected with an EBP50 expressing plasmid (EBP-231) when compared with control cells. There was also a statistically significant increase in spontaneous apoptosis in EBP-231 cells accompanied by an attenuation in ERK activity. Altogether, our results suggest that restoring EBP50 expression could suppress breast cancer cell proliferation by promoting cell apoptosis and inhibiting ERK activity, and that EBP50 may be a target for development of diagnostics and therapeutics in breast cancer. | ||
| 650 | 4 | |a Anchorage-independent growth | |
| 650 | 4 | |a Colony formation | |
| 650 | 4 | |a Cell cycle | |
| 650 | 4 | |a Apoptosis | |
| 650 | 4 | |a MAPK | |
| 700 | 1 | |a Sun, Li-Cui |4 aut | |
| 700 | 1 | |a Liu, Hua |4 aut | |
| 700 | 1 | |a Huang, Yan |4 aut | |
| 700 | 1 | |a Li, Yang |4 aut | |
| 700 | 1 | |a He, Junqi |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Amino acids |d Springer Vienna, 1991 |g 38(2009), 4 vom: 11. Dez., Seite 1261-1268 |w (DE-627)170882225 |w (DE-600)1121341-3 |w (DE-576)040093573 |x 0939-4451 |7 nnns |
| 773 | 1 | 8 | |g volume:38 |g year:2009 |g number:4 |g day:11 |g month:12 |g pages:1261-1268 |
| 856 | 4 | 1 | |u https://doi.org/10.1007/s00726-009-0437-2 |z lizenzpflichtig |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a SYSFLAG_A | ||
| 912 | |a GBV_OLC | ||
| 912 | |a SSG-OLC-PHA | ||
| 912 | |a SSG-OLC-DE-84 | ||
| 912 | |a GBV_ILN_4012 | ||
| 912 | |a GBV_ILN_4219 | ||
| 951 | |a AR | ||
| 952 | |d 38 |j 2009 |e 4 |b 11 |c 12 |h 1261-1268 | ||